JUN 17, 2021 8:00 AM PDT

How T Cells Sense Dangerous Invaders

WRITTEN BY: Tara Fernandez

T cells form a major part of our immune defenses, protecting us against the constant barrage of potentially pathogenic pathogens in our environment. Now, immunologists from Monash University reveal new insights on the intricacies surrounding T cell activation upon encountering such pathogenic threats.

In a study published in the journal Science, a team led by Nicole La Gruta found that to generate a robust activating signal, T cells need to latch on to pathogens such as viruses in a specific orientation. T cell receptors on the surface of these immune cells latch on to fragments of infectious agents called antigens, presented on the surface of infected cells. This critical recognition event triggers a cascade of molecular events leading to the destruction and elimination of an infected cell.

"The central issue is that there are millions of different T cell receptors (TCRs) in the human body, and a vast array of viruses, making it difficult to understand the rules around how T cell receptor recognition of a virus drives T cell activation. Indeed, it is a problem that has remained contentious for over 25 years" explained La Gruta.

Using a suite of experimental technologies including super-resolution microscopy, biochemical assays and in vitro and animal models, La Gruta and colleagues found that the orientation in which the TCR binds to its target determines if the T cell is activated. 

"This is an advance in our fundamental understanding of how a T cell needs to 'see' pathogenic antigens in order to be activated," said La Gruta. "It has clarified a critical mechanism essential for effective T cell immunity. It is also relevant to the ongoing development of immunotherapies that aim to boost the activation of T cells."

 


Source: Science, Monash University.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 05, 2021
Technology
Top Ways to Make the Most out of Your Ethernet
AUG 05, 2021
Top Ways to Make the Most out of Your Ethernet
Today, the Ethernet connection has emerged as one of the most popular ways to make the most out of an internet connectio ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 31, 2021
Immunology
Convalescent Plasma Therapy for COVID-19 Doesn't Work
AUG 31, 2021
Convalescent Plasma Therapy for COVID-19 Doesn't Work
After encountering an infectious agent, the immune system begins churning out antibodies—Y-shaped warriors that ne ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 03, 2021
Cell & Molecular Biology
Is a Venom-Like Molecule Involved in COVID-19 Mortality?
SEP 03, 2021
Is a Venom-Like Molecule Involved in COVID-19 Mortality?
Scientists have sought to learn more about why some people get severe COVID-19 while others have only mild cases. We kno ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
Loading Comments...